Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2014 · 10-Q
Revenue$1.19M$1.19M+111.4% vs Q2 2013 Net Income-$1.59M-$1.59MN/M vs Q2 2013 EPS Diluted-$0.03-$0.03N/M vs Q2 2013 Operating Income-$2,215,588N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,724,971N/M Margins · derivedOperating margin-186.4%+200.9 pt vs Q2 2013
Net margin-134.0%+106.4 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 11, 2014 · 42 d after period end